Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma
NCT03793907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2023-04-10
Summary
This trial studies how well strength training works in improving bone health, pain, and quality of life in patients with multiple myeloma. Weekly physical activity may improve bone recovery, reduce pain, and increase quality of life in patients with multiple myeloma.
Conditions
- Plasma Cell Myeloma
Interventions
- DEVICE
-
FitBit
Wear Fitbit
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Ancillary studies
- OTHER
-
Resistance Training
Complete strength training
- BEHAVIORAL
-
STEPS to Enhance Physical Activity
Complete a walking program
Sponsors & Collaborators
-
Roswell Park Cancer Institute
lead OTHER
Principal Investigators
-
Jens Hillengass · Roswell Park Cancer Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-17
- Primary Completion
- 2022-02-28
- Completion
- 2022-11-10
Countries
- United States
Study Locations
More Related Trials
-
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
NCT05257785 ·Status: RECRUITING ·Phase: NA
-
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
NCT00809575 ·Status: UNKNOWN
-
The Prognostic Value of CPCs Quantified by Flow Cytometry in Patients With Multiple Myeloma: a Prospective, Multicenter Clinical Trial
NCT06228794 ·Status: RECRUITING
-
The Ambient Light Multiple Myeloma Study
NCT05737732 ·Status: RECRUITING ·Phase: NA
-
Quantitative MRI for Myelofibrosis
NCT01973881 ·Status: RECRUITING
-
Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma
NCT04530812 ·Status: COMPLETED ·Phase: NA
-
CC-4047 in Treating Patients With Myelofibrosis
NCT00669578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
NCT00099047 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma
NCT00503763 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT06245941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Correlative Biomarker Study in Patients With Myeloproliferative Disorders
NCT00665067 ·Status: COMPLETED
-
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
NCT05817331 ·Status: COMPLETED
-
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
NCT01793051 ·Status: COMPLETED ·Phase: PHASE2
-
Mycobiome Supporting Diet to Reduce GI Toxicity Associated With ASCT
NCT04685525 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
NCT00541164 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enhancing Cancer Survivorship With Pickleball
NCT06048822 ·Status: COMPLETED ·Phase: NA
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894 ·Status: RECRUITING ·Phase: NA
-
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
NCT00002850 ·Status: COMPLETED ·Phase: PHASE3
-
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
NCT00489372 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
NCT00296205 ·Status: WITHDRAWN ·Phase: PHASE2
-
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
NCT00093678 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
NCT06122831 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis
NCT01014546 ·Status: TERMINATED ·Phase: PHASE1
-
Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
NCT03068637 ·Status: COMPLETED ·Phase: NA
-
Reishi Mushroom Extract for Fatigue and/or Arthralgias/Myalgias in Patients With Breast Cancer on Aromatase Inhibitors
NCT06028022 ·Status: RECRUITING ·Phase: PHASE2